Head of Product Launch Program Management; Rare Disease

Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity.

Rezolute's lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI). As Rezolute expands its medical and scientific focus into tumor-related hyperinsulinism (tumor HI), most commonly related to pancreatic neuroendocrine tumors (insulinomas) or para neoplastic hypoglycemia (NICTH), the company is committed to advancing novel therapeutic strategies that address this rare and complex form of hypoglycemia associated with insulin‑secreting tumors and related neuro‑oncology disorders.

More information can be found at

The Director, Product Launch Program Management is a member of the Program Management Office (PMO), reporting to the Senior Vice President, Operations, and directly supporting the Commercial Product Launch Lead (Head of Marketing). The PLPM owns the integrated launch plan by indication and by market across the U.S. and priority ex-U.S. countries, and facilitates, consolidates, organizes, documents, and measures that plan so the Product Launch Lead and functional leaders can make decisions and deliver against it.

The role supports establishment of the launch strategy with specific responsibility to make it complete, current, and executable. Working within the company's governance model, the role works daily within the PMO enabling coordination, dependency determination, awareness and cross functional planning with program managers supporting the Development and Technical Operations teams.

Success requires a working understanding of each contributing function's scope of work, with emphasis on critical coordination of Commercial, Regulatory, Medical Affairs, Supply and Quality, and the ability to engage the working team credibly on scope, tasks, dependencies, risks, and outcomes. As Rezolute advances concurrent launches across multiple indications in the U.S. and ex-U.S., this role may expand to build and manage a team of Launch Program Managers.

This can be a remote role based in the United States, with travel as necessary to Rezolute headquarters in Redwood City, CA, and to launch team, partner, and ex-U.S. working sessions.

• Own a single, authoritative integrated launch plan (ILP) by indication and by market, covering scope, tasks, owners, timelines, critical path, and cross-functional dependencies, including shared versus indication‑specific work streams.
• Consolidate inputs from Commercial, Market Access, Medical Affairs, Regulatory, Clinical, Manufacturing, Quality, Supply Chain, Finance, and Legal, and reconcile conflicts in timing, assumptions, and ownership.
• Manage plan changes through PMO governance, re‑baselining when scope, indication sequencing, or timing changes and communicating impacts to the team.

• Facilitate launch team and working team meetings on behalf of the Head of Operations and/or Product Launch Lead, driving agendas and pre‑reads to document decisions, actions, and ownership.
• Works daily with amongst the launch working team to communicate, coordinate, influence, problem solve and drive issue resolution; escalation critical‑path issues, dependencies and risks in a timely way, with options.
• Coordinate Launch Readiness Reviews (LRR) and day‑of‑approval and launch‑window…